Uzbekistan To Implement Large Pharma Projects

 
• By Mainbayar Badarch

Uzbekistan is the most populous country in Central Asia with 36 million people. The country has the only plant in Central Asia specializing in insulin production for the treatment of diabetes. Uzbek authorities aim to develop 90 pharma projects worth $1.2bn by 2026.  

Uzbekistan map
• Source: Shutterstock

Uzbekistan annually consumes $1.6bn worth of pharmaceutical products. Most of this volume – almost $1.2bn in production – is imported.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business Strategy

More from In Vivo